Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

Apr 24, 2018

SELL
$107.21 - $151.94 $4.3 Million - $6.09 Million
-40,072 Closed
0 $0
Q4 2017

Jan 29, 2018

BUY
$118.58 - $151.28 $464,952 - $593,168
3,921 Added 10.85%
40,072 $5.93 Million
Q3 2017

Oct 17, 2017

BUY
$114.6 - $136.81 $4.14 Million - $4.95 Million
36,151
36,151 $4.24 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Dock Street Asset Management Inc Portfolio

Follow Dock Street Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dock Street Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dock Street Asset Management Inc with notifications on news.